Helen Louise Collins - 15 Nov 2023 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Director
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Helen Louise Collins
Issuer symbol
IOBT
Transactions as of
15 Nov 2023
Net transactions value
$0
Form type
4
Filing time
17 Nov 2023, 16:47:01 UTC
Previous filing
17 Nov 2023
Next filing
15 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +64,238 $0.000000 64,238 15 Nov 2023 Common Stock 64,238 $0.9800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of these options vest each month over three years, subject to the reporting person's continued service through each applicable vesting date, and subject to 100% acceleration upon a change of control.